Market Overview

Jim Cramer Weighs In On Valeant, Corning And Synergy Pharmaceuticals

Related VRX
Jim Cramer Weighs In On Royal Caribbean Cruises, Allergan And More
Cantor Fitzgerald: 18 Drug Companies With Catalysts Worth Watching
The Dangers Of Portfolio Concentration (Seeking Alpha)
Related GLW
Jim Cramer Shares His Thoughts On Altria, Corning And More
Benzinga's Top Upgrades, Downgrades For May 3, 2018
Stock buybacks surge: But who gets the biggest bang for the buck? (Seeking Alpha)

Jim Cramer spoke on CNBC's Mad Money about Valeant Pharmaceuticals Intl Inc (NYSE: VRX). He thinks the company should do an equity offering to reduce its huge debt. There is still a large short position in the stock and some investors decided to cover it, because the downside is now quantified. He doesn't see Valeant as a good long position.

Cramer thinks Corning Incorporated (NYSE: GLW) is having a good run and the stock is a buy.

Cramer can't recommend Synergy Pharmaceuticals Inc (NASDAQ: SGYP) for anything other than a speculation. It's still in an early stage and it didn't report a good quarter.

Posted-In: CNBC Mad Money Jim CramerMedia


Related Articles (GLW + SGYP)

View Comments and Join the Discussion!